Cogent Biosciences, Inc. (COGT)
35.84
+0.63
(+1.79%)
USD |
NASDAQ |
Apr 06, 12:48
Cogent Biosciences SG&A Expense (TTM) : 63.58M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Syndax Pharmaceuticals, Inc. | 179.68M |
| Vera Therapeutics, Inc. | 100.22M |
| Terns Pharmaceuticals, Inc. | 32.24M |
| Nuvalent, Inc. | 107.34M |
| Insmed, Inc. | 701.17M |